Hyperuricemia Clinical Trials

13 recruiting

Hyperuricemia Trials at a Glance

19 actively recruiting trials for hyperuricemia are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Shanghai, Örebro, and Guangzhou. Lead sponsors running hyperuricemia studies include Sun Yat-sen University, Örebro University, Sweden, and Hospital Universitario La Paz.

Browse hyperuricemia trials by phase

Treatments under study

About Hyperuricemia Clinical Trials

Looking for clinical trials for Hyperuricemia? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperuricemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperuricemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 119 of 19 trials

Recruiting
Phase 2

The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

Primary Gout and Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd.340 enrolled1 locationNCT07362355
Recruiting
Not Applicable

The Effects of a Probiotic Food Supplement in Hyperuricaemia

Hyperuricemia With or Without Gout
Örebro University, Sweden99 enrolled1 locationNCT07141888
Recruiting
Phase 2

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

GoutGouty ArthritisHyperuricemia+4 more
Arthrosi Therapeutics25 enrolled8 locationsNCT07116746
Recruiting
Not Applicable

Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)

HypertensionHyperuricemiaHyperglycemia+2 more
China National Center for Cardiovascular Diseases100 enrolled1 locationNCT07400549
Recruiting
Phase 1Phase 2

A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease

HyperuricemiaHypouricemia, Renal
Intelligem Therapeutics Australia Pty Ltd.60 enrolled6 locationsNCT06310967
Recruiting
Phase 4

Effect of Dotinurad in Hyperuricemia With Hypertension

HypertensionHyperuricemia or Gout
Saga University360 enrolled1 locationNCT06834230
Recruiting
Phase 1

A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia

Healthy VolunteersHyperuricemia
Novo Nordisk A/S60 enrolled2 locationsNCT06859073
Recruiting

This Study is to Estimate the Efficacy of Hemodialysis Alone for Uric Acid Clearance in Patients on Hemodialysis. In Order to Evaluate the Need of Adjuvant Uric Acid Lowering Therapy

HyperuricemiaHemodialysis
Sohag University100 enrolled1 locationNCT07144332
Recruiting

Effects of Fibres Combined With Probiotics on Uric Acid in an ex Vivo Fermentation Model

Hyperuricemia
Örebro University, Sweden15 enrolled1 locationNCT06981663
Recruiting
Not Applicable

Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia

Hyperuricemia or Gout
OMNIFARMA LLC100 enrolled1 locationNCT07002762
Recruiting
Phase 1

Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia

GoutHyperuricemia
Shenyang Sunshine Pharmaceutical Co., LTD.60 enrolled1 locationNCT06629376
Recruiting
Phase 4

Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets

Hyperuricemia or GoutNephrolithiasis
Huashan Hospital312 enrolled1 locationNCT06966635
Recruiting
Not Applicable

Manual Acupuncture (MA) for Asymptomatic Hyperuricemia (HUA)

Asymptomatic Hyperuricemia
Shenghao Tu260 enrolled1 locationNCT06824376
Recruiting

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Diabetes MellitusInsulin Sensitivity/ResistanceObesity+16 more
Osaka Metropolitan University2,000 enrolled1 locationNCT06694012
Recruiting
Not Applicable

GOS and the Management of Hyperuricemia

Subjects With Hyperuricemia
Sun Yat-sen University70 enrolled1 locationNCT06630377
Recruiting
Phase 4

CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea

Sleep ApneaHyperuricemiaDyslipidemias
Hospital Universitario La Paz220 enrolled1 locationNCT06463561
Recruiting
Not Applicable

Prebiotics and the Management of Hyperuricemia

Subjects With Hyperuricemia
Sun Yat-sen University160 enrolled2 locationsNCT06420401
Recruiting

Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases

Diabetes MellitusObesityHypertension+2 more
Peking Union Medical College Hospital200 enrolled1 locationNCT05476627
Recruiting
Phase 4

To compare the efficacy & safety profile of Febuxostat with Allopurinol in local Pakistani hyperuricemic patients.

GoutHyperuricemia
PharmEvo (Pvt.) Ltd.120 enrolled1 locationACTRN12612000434897